World Alzheimer's Month

United States, Canada, United Kingdom, Ireland, Australia, New Zealand, India, Japan, China, Singapore, Malaysia, South Africa, Nigeria, Brazil, Argentina, Mexico, France, Germany, Spain, Italy, Netherlands, Sweden, Norway, Denmark, Finland, Switzerland, Austria, Belgium, Portugal, Greece

About

World Alzheimer’s Month is observed throughout September as a time to raise awareness of Alzheimer’s disease and other forms of dementia. It encourages greater understanding of how these conditions affect individuals, families, and caregivers, while helping reduce stigma and promoting compassion for everyone touched by memory loss.

Throughout the month, communities, health organizations, and advocates share information about prevention, early signs, diagnosis, treatment, and support services. It is also an opportunity to recognize caregivers, honor the experiences of people living with Alzheimer’s, and encourage conversations that can lead to stronger support, better research, and more dementia-friendly communities.

History

World Alzheimer’s Month is observed throughout September as an international campaign to raise awareness of Alzheimer’s disease and other forms of dementia. It was established by Alzheimer’s Disease International (ADI), the global federation of Alzheimer’s and dementia associations, in 2012. The initiative expanded earlier international awareness efforts by creating an entire month in which organizations, health professionals, researchers, caregivers, and affected families could coordinate education and advocacy activities.

Its origins lie in the growing recognition that dementia is a worldwide public-health and social issue rather than a concern limited to individual families or particular countries. ADI, founded in 1984, helped connect national Alzheimer’s associations and promote a shared international voice. Over time, its awareness campaigns drew attention to the need for earlier recognition, better support for caregivers, improved research, and stronger public policies. Establishing September as World Alzheimer’s Month gave these priorities a sustained period of visibility each year.

The observance has evolved alongside changes in how dementia is understood. Earlier campaigns often concentrated on correcting misconceptions and encouraging people to seek information. More recent efforts also address risk reduction, diagnosis, access to care, the experiences of people living with dementia, and the social and economic effects on families and communities. Annual themes and locally organized events allow participating groups to focus on different aspects of the subject while remaining part of a shared global campaign.

Culturally, World Alzheimer’s Month helps challenge stigma and the isolation that can accompany memory loss and cognitive decline. Public talks, educational programs, fundraising campaigns, memory-support initiatives, media coverage, and caregiver activities encourage communities to discuss dementia more openly and compassionately. By bringing together personal experiences, medical knowledge, and advocacy, the September observance emphasizes that people living with Alzheimer’s deserve dignity, inclusion, and meaningful support, while also recognizing the essential role of caregivers and families.

Timeline

1906
Alois Alzheimer presented the clinical and pathological findings from the case of Auguste Deter at a psychiatric meeting in Tübingen, describing the plaques and tangles later associated with Alzheimer’s disease.
1910
Psychiatrist Emil Kraepelin used the name "Alzheimer’s disease" in the eighth edition of his textbook Psychiatrie, crediting Alois Alzheimer’s work.
1976
Neurologist Robert Katzman published a landmark editorial in Archives of Neurology arguing that Alzheimer’s disease was a common, major cause of dementia rather than a rare presenile condition.
1984
George Glenner and C. W. Wong reported the purification and characterization of beta-amyloid from cerebral amyloid angiopathy, a key advance in identifying the protein central to Alzheimer’s plaques.
1991
Researchers reported a mutation in the amyloid precursor protein (APP) gene associated with hereditary early-onset Alzheimer’s disease, providing major genetic evidence for the role of amyloid.

Upcoming dates

Sources

Same day

Related